The 60 Minutes show here in the U.S. has done sobering segments over the years on risky, unproven stem cell clinics, but now there is a new episode of 60 Minutes Australia that is the polar opposite: it mostly made a mess of things with its fluffy coverage of the story of a wonderful little …
60 Minutes Australia Pushes Unproven Stem Cells for Cerebral Palsy Read More »
Australian stem cell biotech Mesoblast announced that it has received regenerative medicine advanced therapy (RMAT) designation from the U.S. FDA. This is very good news for the company and an encouraging development for the field. Interestingly, last month the FDA clarified that there is expanded RMAT designation that can include gene therapies too. At the Meeting …
Mesoblast gets FDA RMAT; List of 10 total designations so far Read More »
Enjoy! A Sunday brunch for the brain of science news, helpful links, and notable new papers including on stem cells. News and links CBER Director Focuses on Flexibility to Advance Regenerative Medicines Lab-Grown Blood Stem Cells Produced at Last Transplanted stem cells become eggs in sterile mice Maryland fund awards $8.5 million for stem cell research Positively good news from Asterias …
Stem cells Sunday brunch of good news, fun links, & cool papers Read More »
What’s been up the past week in terms of news in the stem cell world? The Wall Street Journal reports that the New York Stem Cell Foundation (NYSCF) has signed a 20-year lease on a much larger space, in fact twice the current size, in Manhattan. That would seem to be a great sign of …
Stem Cell News Briefs: NYSCF, Sleep & Transplants, NFL legends, & More Read More »
It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more …
Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »
Statins have been hailed as some of the best drugs ever. Given the massive, deadly prevalence of cardiovascular disease, some have even semi-jokingly talked about putting these drugs in the water supply for public health. The growing evidence (e.g. this story) that statins might significantly aid in prevention, delayed progression, or even post-treatment delay of …
Statins dilemma: heart & cancer benefits, but diabetes risk Read More »
Got your new mandatory NIH biosketch all done? I didn’t think so. Want some help? Read on. NIH has done research and come up with a new biosketch for all of us to use with our proposals. It’s not optional. Originally it was going to be required for January 2015 proposals, but now it must …
10 tips on mandatory new NIH biosketch & example Read More »
Remember that old TV show the Odd Couple with very proper Felix Unger and his polar opposite Oscar Madison who has all kinds of baggage? They’ve cloned it into a remake to be on TV soon here in the US in 2015. It seems only fitting then that actual human cloning research has a new …
The Odd Couple of Cloning Research: Mitalipov & Woo Suk Hwang Unite Read More »
What is the role of public education and stem cell tourism? What type of education is available to patients, caregivers and the public? Can public education actually change people’s minds such that they won’t undergo an unproven stem cell-based intervention (SCBI)? These are the questions I will discuss here. But first, let’s just give a …
StemCells, Inc. is one of those stem cell-related biotech companies that we in the field hope will become a big success and help many patients in the future via stem cell technology. There are a lot of obstacles facing such companies. Some are privately held, while others such as StemCells, Inc. are publicly traded (stock …
StemCells, Inc. Faces Lawsuit With Serious Allegations Read More »